Versant Vantage I Gp, L.P.
CIK 0001777651
10% Owner
Filings
9
Latest Sep 23, 2025
Issuers covered
5
Showing
9 of 9
Page 1
Track record
7 of 20 open-market trades scored (35% price coverage) - 13 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 71% | +8.0% | +15.9% | +20.7% | -10.6% |
| 90 days | 7 | 43% | -0.9% | -0.5% | +39.3% | -51.8% |
| 180 days | 7 | 57% | +18.6% | +3.1% | +47.8% | -9.2% |
| 365 days | 7 | 29% | -10.3% | -14.0% | +21.4% | -33.4% |
Issuers
Companies where Versant Vantage I Gp, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 3 | Oct 30, 2024 |
| LVTX | Lava Therapeutics NV | 2 | Sep 23, 2025 |
| OYST | Oyster Point Pharma, Inc. | 2 | Jan 4, 2023 |
| CTNM | Contineum Therapeutics, Inc. | 1 | Apr 11, 2024 |
| RPTX | Repare Therapeutics Inc. | 1 | Jun 7, 2022 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|